FDA Finally OKs First Drug for Hepatorenal Syndrome Pivotal trial data showed terlipressin nearly doubled reversal of the condition Sep 15, 2022
First TYK2 Inhibitor for Psoriasis Wins FDA Approval Deucravacitinib significantly outperformed apremilast in two randomized trials Sep 11, 2022
First Approved Treatment for Generalized Pustular Psoriasis Spesolimab led to complete clearance of pustules within a week in more than half of patients Sep 07, 2022
FDA Data Link Diabetes Drug Class to Gallbladder Disease FAERS analysis turns up dozens of cases of acute cholecystitis tied to GLP-1 receptor agonists Aug 30, 2022
FDA Warns on Potential for Monkeypox Spread via Fecal Transplant Agency urges additional protections around donor screening Aug 24, 2022
Biden Administration Authorizes Intradermal Use of Monkeypox Vaccine Move is expected to increase available doses by five-fold Aug 10, 2022
False Claims About COVID Vax Animal Testing Resurface Misinformation promoted by Texas lawmaker in 2021 pops up again on Twitter Aug 09, 2022
I Got Monkeypox Drugs -- Not Everyone Is So Lucky Increasing access to testing, vaccination, and treatment is critical to slowing the spread Aug 03, 2022
FDA OKs First Interchangeable Ranibizumab Biosimilar When available, Cimerli qualifies for pharmacy-level substitution for reference drug Aug 03, 2022
Are Skin Lesion Analyzers Ready for Prime Time? FDA panel not fully on board to reclassify computer-aided melanoma detection devices Jul 30, 2022
Dear Insurers: It's Time to Cover Weight Loss Drugs Universal coverage can increase medication access and improve population health Jul 27, 2022
Banned Supplements Still Available to Buy Online After FDA Warnings FDA should follow up on warning letters, researchers urge Jul 26, 2022
Topical JAK Inhibitor OK'd for Repigmentation of Vitiligo Significantly more patients achieved 75%, 90% improvement Jul 19, 2022
FDA Getting Tougher on Birth Tissue Companies Agency calls out manufacturer on orthopedic indications Jul 06, 2022
FDA Warns of Increased Mortality Risk With Duvelisib Drug approved for adults with CLL/SLL Jul 01, 2022
FDA Expands Use of Weight-Loss Drug to Adolescents Qsymia now approved for teens with obesity, along with diet and exercise Jun 28, 2022
Should Young and Healthy Patients Take Paxlovid? The antiviral has not been shown to be valuable in this population Jun 26, 2022
Drugmaker Pulls Third-Line PARP Inhibitor Approval in Ovarian Cancer Decision on rucaparib follows negative OS signal and "discussions" with FDA Jun 17, 2022
FDA OKs Risankizumab for Crohn's Disease Approval marks the third indication for the IL-23 inhibitor in adults Jun 17, 2022
FDA Allows mRNA COVID Vaccines in Kids 6 Months and Up Vaccines expected to protect against most severe outcomes, says FDA Commissioner Jun 17, 2022
FDA Approves First Systemic Treatment for Alopecia Areata Four to 10 times as many patients met hair-regrowth endpoint with JAK inhibitor versus placebo Jun 13, 2022
FDA Panel Backs Gene Tx for Degenerative Brain Disorder in Kids Advisers unanimously recommend approval for pediatric ALD patients without HLA-matched donors Jun 10, 2022
It's High Noon for Dietary Supplements The user fee legislation in Congress proposes useful regulations, but doesn't go far enough Jun 10, 2022
FDA Pulls Lymphoma Approvals for PI3K Inhibitor Umbralisib Worse overall survival observed despite improvements in progression-free survival Jun 01, 2022
Abbott Formula Plant Was 'Unacceptably Insanitary,' FDA Chief Tells Lawmakers Abbott official says the company is "deeply, deeply sorry" about the formula shortage May 26, 2022
FDA OKs First Novel Nonsteroidal Topical for Plaque Psoriasis in 25 Years Complete, near-complete clearance in 35-40% of patients treated with tapinarof cream 1% May 24, 2022
First Treatment Approved for Eosinophilic Esophagitis FDA expands dupilumab's label to treat inflammatory condition May 20, 2022
FDA Rejects Cheap Antidepressant to Treat Early COVID David Boulware, who submitted the EUA for fluvoxamine, argues the agency is "behind the times" May 17, 2022
First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetes Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
Restrictions on Mifepristone a Barrier to Miscarriage Care, Surveys Show Over a third of respondents do not prescribe the drug for early pregnancy loss, despite efficacy May 10, 2022
Early Alzheimer's Test Gets FDA Nod First in vitro diagnostic to detect amyloid in early disease setting May 05, 2022
Two New Regimens Win FDA Approval for H. Pylori Infection Dual and triple vonoprazan-based treatments offer physicians another set of options May 04, 2022
How Far Should the Menthol Ban Go? It's time to ban menthol in cigarettes -- but not necessarily in all tobacco products May 02, 2022
FDA OKs New Nonstimulant Option for Adult ADHD New selective norepinephrine reuptake inhibitor is no longer just for kids May 02, 2022
FDA Proposes Ban on Menthol Cigarettes "Long-awaited action" should reduce youth smoking, health disparities Apr 28, 2022
FDA Approves First Drug for Recurrent Yeast Infections Vivjoa indicated for infertile or postmenopausal women Apr 28, 2022
FDA Issues Warning on Prenatal Genetic Tests Relying on results could lead to inappropriate medical decisions, agency warns Apr 19, 2022
First Topical Therapy for Facial Angiofibroma Nabs FDA Approval New alternative to dermabrasion, laser treatment, surgery Apr 04, 2022
ALS Drug Needs More Evidence, FDA Advisors Say But vote was close and panelists remain hopeful about AMX0035 Mar 31, 2022
Another Oral Testosterone Undecanoate OK'd for Hypogonadism FDA approval of Tlando follows in the footsteps of Jatenzo Mar 29, 2022
